These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

687 related items for PubMed ID: 29873436

  • 1. Systematic review with meta-analysis: Vonoprazan, a potent acid blocker, is superior to proton-pump inhibitors for eradication of clarithromycin-resistant strains of Helicobacter pylori.
    Li M, Oshima T, Horikawa T, Tozawa K, Tomita T, Fukui H, Watari J, Miwa H.
    Helicobacter; 2018 Aug; 23(4):e12495. PubMed ID: 29873436
    [Abstract] [Full Text] [Related]

  • 2. Comparative study: Vonoprazan and proton pump inhibitors in Helicobacter pylori eradication therapy.
    Sakurai K, Suda H, Ido Y, Takeichi T, Okuda A, Hasuda K, Hattori M.
    World J Gastroenterol; 2017 Jan 28; 23(4):668-675. PubMed ID: 28216974
    [Abstract] [Full Text] [Related]

  • 3. Efficacy of Vonoprazan for Helicobacter pylori Eradication.
    Kiyotoki S, Nishikawa J, Sakaida I.
    Intern Med; 2020 Jan 15; 59(2):153-161. PubMed ID: 31243237
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Vonoprazan-based triple therapy is non-inferior to susceptibility-guided proton pump inhibitor-based triple therapy for Helicobacter pylori eradication.
    Tanabe H, Yoshino K, Ando K, Nomura Y, Ohta K, Satoh K, Ichiishi E, Ishizuka A, Otake T, Kohgo Y, Fujiya M, Okumura T.
    Ann Clin Microbiol Antimicrob; 2018 Jun 28; 17(1):29. PubMed ID: 29950163
    [Abstract] [Full Text] [Related]

  • 7. Helicobacter pylori Eradication with Proton Pump Inhibitors or Potassium-Competitive Acid Blockers: The Effect of Clarithromycin Resistance.
    Matsumoto H, Shiotani A, Katsumata R, Fujita M, Nakato R, Murao T, Ishii M, Kamada T, Haruma K, Graham DY.
    Dig Dis Sci; 2016 Nov 28; 61(11):3215-3220. PubMed ID: 27659671
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Systematic review with meta-analysis: the efficacy of vonoprazan-based triple therapy on Helicobacter pylori eradication.
    Jung YS, Kim EH, Park CH.
    Aliment Pharmacol Ther; 2017 Jul 28; 46(2):106-114. PubMed ID: 28497487
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Vonoprazan Triple and Dual Therapy for Helicobacter pylori Infection in the United States and Europe: Randomized Clinical Trial.
    Chey WD, Mégraud F, Laine L, López LJ, Hunt BJ, Howden CW.
    Gastroenterology; 2022 Sep 28; 163(3):608-619. PubMed ID: 35679950
    [Abstract] [Full Text] [Related]

  • 13. Vonoprazan-based therapies versus PPI-based therapies in patients with H. pylori infection: Systematic review and meta-analyses of randomized controlled trials.
    Liu L, Shi H, Shi Y, Wang A, Guo N, Li F, Nahata MC.
    Helicobacter; 2024 Sep 28; 29(3):e13094. PubMed ID: 38790090
    [Abstract] [Full Text] [Related]

  • 14. Clinical impact of vonoprazan-based dual therapy with amoxicillin for H. pylori infection in a treatment-naïve cohort of junior high school students in Japan.
    Gotoda T, Kusano C, Suzuki S, Horii T, Ichijima R, Ikehara H.
    J Gastroenterol; 2020 Oct 28; 55(10):969-976. PubMed ID: 32666199
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Vonoprazan-containing Helicobacter pylori triple therapies contribution to global antimicrobial resistance.
    Graham DY, Lu H, Shiotani A.
    J Gastroenterol Hepatol; 2021 May 28; 36(5):1159-1163. PubMed ID: 32918832
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Effectiveness and safety of vonoprazan-based regimen for Helicobacter pylori eradication: A meta-analysis of randomized clinical trials.
    Yang C, Li S, Huang T, Lin H, Jiang Z, He Y, Yuan J, An H.
    J Clin Pharm Ther; 2022 Jul 28; 47(7):897-904. PubMed ID: 35247003
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 35.